John A. Latham, Chief Scientific Officer at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 3,636 shares at $23.62 ($83K) on 2016-12-01, disclosed to the SEC on 2016-12-05.
Scheduled sale ($83k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.64 | 3,136 | $71K | 85.7% |
| 2 | $23.62 | 500 | $12K | 14.3% |
| Total | $22.77 avg | 3,636 | $83K | 100% |
| Filing → |
| ALDR | SELL | 2018-09-06 | $450K | — | Filing → |
| ALDR | SELL | 2018-08-02 | $489K | — | Filing → |
| ALDR | SELL | 2018-07-03 | $387K | — | Filing → |